Drug eluting coronary stents

British Medical Journal

Volumn 325, Issue 7376, 2002, Pages 1315-1316

  Jenkins, N P ^a   Prendergast, Bernard D ^a   Thomas, M ^b  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; PACLITAXEL; RAPAMYCIN;

CLINICAL TRIAL; CONTROLLED DRUG RELEASE; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; COST EFFECTIVENESS ANALYSIS; DRUG DELIVERY SYSTEM; DRUG EFFICACY; EDITORIAL; ENDOTHELIUM CELL; HUMAN; PRIORITY JOURNAL; RESTENOSIS;

EID: 0037039018     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.325.7376.1315     Document Type: Editorial

References (8)

1. Serruys PW, Jaegere Pd, Kiemenij F, Macaya C, Rutsch W, Heyndrickx G, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994;331:489-95.
2. Gerschlick AH, Baron J. Dealing with in-stent restenosis. Heart 1998;79:319-23.
3. Lincoff AM, Califf RM, Moliterno DJ, Ellis SG, Ducas J, Kramer JH, et al. Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. N Engl J Med 1999;341:318-27.
4. Teirstein PS, Massullo V, Jani S, Popma JJ, Mintz GS, Russo RJ, et al. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med 1997;336:1697-1703.
5. Raizner AE, Oesterle SW, Waksman R, Serruys PW, Colombo A, Lim YL, et al. Inhibition of restenosis with beta-emitting radiotherapy: Report of the proliferation reduction with vascular energy trial (PREVENT). Circulation 2000;102:951-8.
6. Morice MA, Serruys PW, Sousa JE, Fajadet J, Hayashi EB, Perin M, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-80.
7. Grube E, Silber S, Hauptmann K. TAXUS I prospective, randomized, double blind comparison of NIRX TM stents coated with paclitaxel in a polymer carrier in de novo coronary lesions compared with uncoated controls. Circulation 2001;104:II-463.
8. Gershlick A, Descheerder I, Chevalier B. Local drug delivery to inhibit coronary artery restenosis. Data from ELUTES (evaluation of paclitaxel eluting stent) clinical trial. Circulation 2001;104:II-416.